A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 20, 2022

Primary Completion Date

June 26, 2026

Study Completion Date

June 26, 2026

Conditions
Myasthenia Gravis
Interventions
DRUG

Nipocalimab

Nipocalimab will be administered as an IV infusion.

Trial Locations (19)

15224

TERMINATED

University of Pittsburgh Medical Center, Pittsburgh

17033

RECRUITING

Penn State Milton S Hershey Medical Ctr, Hershey

19106

RECRUITING

Childrens Hospital Of Philadelphia, Philadelphia

33613

RECRUITING

University of South Florida Morsani Center for Advanced Healthcare, Tampa

48109

RECRUITING

C.S. Mott Children's Hospital, Ann Arbor

66045

COMPLETED

University of Kansas Medical Center, Lawrence

80045

RECRUITING

Children's Hospital Colorado, Aurora

85016

RECRUITING

Phoenix Children's Hospital, Phoenix

90027

RECRUITING

Childrens Hospital Los Angeles, Los Angeles

94158

RECRUITING

UCSF Benioff Children's Hospital, San Francisco

94304

RECRUITING

Lucile Packard Children's Hospital Stanford, Palo Alto

399-8288

RECRUITING

Nagano Children's Hospital, Azumino-shi

260 8677

RECRUITING

Chiba University Hospital, Chiba

889-1692

RECRUITING

University of Miyazaki Hospital, Miyazaki

663-8501

RECRUITING

Hyogo College of Medicine Hospital, Nishinomiya-Shi

330-8777

RECRUITING

Saitama Prefecture Children's Medical Center, Saitama Shi

162-8666

RECRUITING

Tokyo Women's Medical University Hospital, Shinjuku-ku

2333 ZA

RECRUITING

Leiden University Medical Center, Leiden

80 211

RECRUITING

Uniwersyteckie Centrum Kliniczne, Gdansk

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY